Bristol-Myers Squibb - Company & Market Research Reports

Home /
Companies /
Bristol-Myers Squibb

Bristol-Myers Squibb is a pharmaceutical company that develops products for various diseases, such as oncology, virology, cardiovascular diseases, serious mental illness, and immunoscience. The company has delivered 12 new medicines to patients in the past 7 years. It also provides products for Alzheimer's disease, atherosclerosis/thrombosis, hepatitis, HIV/AIDS, solid organ transplant rejection, and a wide variety of other diseases and disorders. Bristol-Myers Squibb was founded in 1990 and is based in Uxbridge, United Kingdom.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 464
Immune Disorders Drugs 194
Cardiovascular Drugs 153
Biopharmaceuticals 132
Infectious Diseases Drugs 121
Central Nervous System Drugs 104
Drug Discovery 102
Endocrine and Metabolic Disorders Drugs 102
Clinical Trials 93
Musculoskeletal Disorders Drugs 93
Pharmaceuticals 88
Leukemia Drugs 82
Hematological Drugs 81
Liver and Kidney Disorders Drugs 74
Lymphoma Drugs 64
Dermatological Drugs 58
Diabetes Drugs 54
Skin Cancer Drugs 50
Brain Cancer Drugs 47
Mental Disorders Drugs 41
Lung Cancer Drugs 40
Respiratory Drugs 38
Immunosuppressive Drugs 36
Gastrointestinal Drugs 34
Drug Delivery 32
Infusions and Injectables 31
Pharmaceutical Intermediates 30
Liver Cancer Drugs 30
Pharmaceutical Manufacturing 27
Analgesics 26
Bladder Cancer Drugs 25
Drugs by Therapeutic Area 23
Kidney Cancer Drugs 22
Antibiotics 22
HIV/AIDS Drugs 22
Breast Cancer Drugs 18
Ovarian Cancer Drugs 17
Colon Cancer Drugs 17
Cervical Cancer Drugs 17
Pancreatic Cancer Drugs 17
Psoriasis Drugs 17
Prostate Cancer Drugs 16
Urological Disorders Drugs 16
Schizophrenia Drugs 16
Cancer Vaccines 14
Thyroid Cancer Drugs 14
Sexual and Reproductive Health Drugs 14
Over the Counter (OTC) Drugs 12
Biosimilars and Biosuperiors 10
Optical Disorders Drugs 8
Generic Drugs 8
Alzheimer's Disease Drugs 8
Transdermal and Transmucosal Drug Delivery 7
Vaccines 7
Uterine Cancer Drugs 7
Cough and Cold Drugs 6
Anti-Obesity Drugs 6
Anxiety Drugs 6
Company Reports 5
Pharmacoeconomics 3
Vitamins and Dietary Supplements 3
Addiction Disorders Drugs 2
Animal Pharmaceuticals 2
Asthma Drugs 2
Inhalers and Nebulisers 1
Anesthetic Drugs 1
Allergy Drugs 1
Bronchitis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



281 reviews

2,381 Results (Page 30 of 120)
- Relevance
  Sort by

Hemoglobinopathies - Market Insights, Competitive Landscape, and Market Forecast - 2030

 Report
July 2024
100 Pages
Global

From

€3292EUR$3,750USD£2,872GBP

Colorectal Cancer Therapeutics Market Report and Forecast 2023-2031

 Report
April 2023
160 Pages
Global

From

€4345EUR$4,949USD£3,791GBP

Rheumatoid Arthritis Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031

 Report
January 2026
185 Pages
Global

From

€3950EUR$4,500USD£3,447GBP

Nephroblastoma Treatment Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

 Report
July 2023
83 Pages
Global

From

€3500EUR$4,271USD£3,161GBP

Psoriatic Arthritis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
October 2022
182 Pages
Global

From

€1756EUR$2,000USD£1,532GBP

NEED HELP FINDING THE RIGHT PRODUCT? Francesca will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Korea Pharmaceutical - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

 Report
January 2026
80 Pages
South Korea

From

€4170EUR$4,750USD£3,638GBP

US Bispecific Antibodies Market & Clinical Pipeline Insight 2028

 Drug Pipelines
August 2023
580 Pages
United States

From

€2397EUR$2,730USD£2,091GBP

€3687EUR$4,200USD£3,217GBP

Type 2 Diabetes Market Size and Share Outlook - Forecast Trends and Growth Analysis Report (2025-2034)

 Report
June 2025
400 Pages
Global

From

€4345EUR$4,949USD£3,791GBP

Hydroxyurea Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

 Report
October 2023
74 Pages
Global

From

€3500EUR$4,271USD£3,161GBP

Rheumatoid Arthritis Market (2021 Edition) - Analysis By Drug Type (NSAIDs, DMARDs, Corticosteroids, Others), Treatment, Diagnosis, By Region, By Country: Market Insights and Forecast with Impact of COVID-19 (2021-2026)

 Report
November 2021
220 Pages
Global

From

€2107EUR$2,400USD£1,838GBP

Global Combination Cancer Immunotherapy Market Opportunity and Clinical Trials Insight 2028

 Report
June 2022
1500 Pages
Global

From

€2225EUR$2,535USD£1,942GBP

€3424EUR$3,900USD£2,987GBP

Kidney Cancer Treatment Drug Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

 Report
May 2023
98 Pages
Global

From

€3500EUR$4,271USD£3,161GBP

Systemic Lupus Erythematosus Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
September 2022
432 Pages
Global

From

€2195EUR$2,500USD£1,915GBP

Rheumatoid Arthritis Drugs Market Report 2025

 Report
September 2025
250 Pages
Global

From

€3942EUR$4,490USD£3,439GBP

Gamma Secretase Inhibitor - Pipeline Insight, 2025

 Clinical Trials
April 2025
60 Pages
Global

From

€1097EUR$1,250USD£957GBP

Thyroid Cancer Treatment Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

 Report
October 2024
84 Pages
Global

From

€3500EUR$4,271USD£3,161GBP

Differentiated Thyroid Cancer Therapeutics Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

 Report
September 2024
82 Pages
Global

From

€3500EUR$4,271USD£3,161GBP

Chronic Urticaria Or Hives - Pipeline Insight, 2025

 Clinical Trials
April 2025
80 Pages
Global

From

€1756EUR$2,000USD£1,532GBP

Glioblastoma Multiforme Treatment Market Report and Forecast 2024-2032

 Report
September 2023
200 Pages
Global

From

€3159EUR$3,599USD£2,757GBP

Merkel Cell Carcinoma Disease Treatment Market - Forecast 2021 to 2026

 Report
January 2022
119 Pages
Global

From

€2930EUR$3,338USD£2,556GBP

€3907EUR$4,450USD£3,408GBP

2,381 Results (Page 30 of 120)
- 1
- 28
- 29
- 30
- 31
- 32

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.